Diagnostics

Novel Protocol with Wesper Cuts Hypoglossal Nerve Stimulation Titration Time by 45%, Enhancing Patient OutcomesNovel Protocol with Wesper Cuts Hypoglossal Nerve Stimulation Titration Time by 45%, Enhancing Patient Outcomes

Novel Protocol with Wesper Cuts Hypoglossal Nerve Stimulation Titration Time by 45%, Enhancing Patient Outcomes

NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Wesper, a leader in home-based sleep diagnostics, has announced significant findings from a…

9 months ago
CS Genetics Appoints Bill Colston, PhD, as Chief Executive OfficerCS Genetics Appoints Bill Colston, PhD, as Chief Executive Officer

CS Genetics Appoints Bill Colston, PhD, as Chief Executive Officer

Experienced life-science entrepreneur to drive next generation of single cell biology SAN DIEGO and CAMBRIDGE, England, Sept. 24, 2024 /PRNewswire/…

9 months ago
Helio Genomics CEO Justin Chen Li Selected to Join Leadership Board of Terasaki Institute for Biomedical InnovationHelio Genomics CEO Justin Chen Li Selected to Join Leadership Board of Terasaki Institute for Biomedical Innovation

Helio Genomics CEO Justin Chen Li Selected to Join Leadership Board of Terasaki Institute for Biomedical Innovation

Brings Expertise in Innovative Approaches to Early-Stage Cancer Detection IRVINE, Calif., Sept. 24, 2024 /PRNewswire/ -- Helio Genomics, an AI-driven…

9 months ago
Healthcare Software As A Service Market Surges to USD 68.5 Billion by 2030, Propelled by 10.7% CAGR – Verified Market Reports®Healthcare Software As A Service Market Surges to USD 68.5 Billion by 2030, Propelled by 10.7% CAGR – Verified Market Reports®

Healthcare Software As A Service Market Surges to USD 68.5 Billion by 2030, Propelled by 10.7% CAGR – Verified Market Reports®

The Healthcare Software as a Service (SaaS) market is primarily driven by the increasing demand for cost-effective and scalable solutions…

9 months ago
Techsomed Appoints Robert E. Gerberich as Chief Commercial Officer and Head of North AmericaTechsomed Appoints Robert E. Gerberich as Chief Commercial Officer and Head of North America

Techsomed Appoints Robert E. Gerberich as Chief Commercial Officer and Head of North America

New Senior Executive to Accelerate U.S. Launch of AI-Powered BioTraceIO™ Software Suite for Image-Guided Ablation Therapy REHOVOT, Israel, Sept. 24,…

9 months ago
PicnicHealth Launches Clinical Services as a New Core Capability, Including Clinical Care for Patients and Virtual Site Capabilities for Life Sciences TeamsPicnicHealth Launches Clinical Services as a New Core Capability, Including Clinical Care for Patients and Virtual Site Capabilities for Life Sciences Teams

PicnicHealth Launches Clinical Services as a New Core Capability, Including Clinical Care for Patients and Virtual Site Capabilities for Life Sciences Teams

SAN FRANCISCO, Sept. 24, 2024 /PRNewswire/ -- Today, PicnicHealth announced the launch of its Clinical Services, featuring a Virtual Clinic for…

9 months ago
Axtria is Revolutionizing Field Force Management for Life Sciences and Pharma CompaniesAxtria is Revolutionizing Field Force Management for Life Sciences and Pharma Companies

Axtria is Revolutionizing Field Force Management for Life Sciences and Pharma Companies

BERKELEY HEIGHTS, N.J., Sept. 24, 2024 /PRNewswire/ -- Life Sciences and Pharma industry leaders are turning to Axtria for cutting-edge solutions that boost…

9 months ago
Schivo Announces Strategic Acquisition of ParMedSchivo Announces Strategic Acquisition of ParMed

Schivo Announces Strategic Acquisition of ParMed

WATERFORD, Ireland, Sept. 24, 2024 /PRNewswire/ -- Schivo is pleased to announce it has acquired ParMed, a renowned novel fluid handling…

9 months ago
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial SitesSpectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites

Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites

DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

9 months ago